174 related articles for article (PubMed ID: 34748558)
1. Cost-effectiveness of point-of-care C-Reactive Protein test compared to current clinical practice as an intervention to improve antibiotic prescription in malaria-negative patients in Afghanistan.
Dickinson S; Yi Chong H; Leslie T; Rowland M; Schultz Hansen K; Boyers D
PLoS One; 2021; 16(11):e0258299. PubMed ID: 34748558
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions.
Oppong R; Jit M; Smith RD; Butler CC; Melbye H; Mölstad S; Coast J
Br J Gen Pract; 2013 Jul; 63(612):e465-71. PubMed ID: 23834883
[TBL] [Abstract][Full Text] [Related]
3. Impact of introduction of rapid diagnostic tests for malaria on antibiotic prescribing: analysis of observational and randomised studies in public and private healthcare settings.
Hopkins H; Bruxvoort KJ; Cairns ME; Chandler CI; Leurent B; Ansah EK; Baiden F; Baltzell KA; Björkman A; Burchett HE; Clarke SE; DiLiberto DD; Elfving K; Goodman C; Hansen KS; Kachur SP; Lal S; Lalloo DG; Leslie T; Magnussen P; Jefferies LM; Mårtensson A; Mayan I; Mbonye AK; Msellem MI; Onwujekwe OE; Owusu-Agyei S; Reyburn H; Rowland MW; Shakely D; Vestergaard LS; Webster J; Wiseman VL; Yeung S; Schellenberg D; Staedke SG; Whitty CJ
BMJ; 2017 Mar; 356():j1054. PubMed ID: 28356302
[No Abstract] [Full Text] [Related]
4. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial.
Althaus T; Greer RC; Swe MMM; Cohen J; Tun NN; Heaton J; Nedsuwan S; Intralawan D; Sumpradit N; Dittrich S; Doran Z; Waithira N; Thu HM; Win H; Thaipadungpanit J; Srilohasin P; Mukaka M; Smit PW; Charoenboon EN; Haenssgen MJ; Wangrangsimakul T; Blacksell S; Limmathurotsakul D; Day N; Smithuis F; Lubell Y
Lancet Glob Health; 2019 Jan; 7(1):e119-e131. PubMed ID: 30554748
[TBL] [Abstract][Full Text] [Related]
5. Overdiagnosis and mistreatment of malaria among febrile patients at primary healthcare level in Afghanistan: observational study.
Leslie T; Mikhail A; Mayan I; Anwar M; Bakhtash S; Nader M; Chandler C; Whitty CJ; Rowland M
BMJ; 2012 Jul; 345():e4389. PubMed ID: 22833603
[TBL] [Abstract][Full Text] [Related]
6. A cost-effectiveness and budget impact analysis of C-reactive protein point-of-care testing to guide antibiotic prescribing for acute respiratory tract infections in primary care settings in Ireland: a decision-analytic model.
Fawsitt CG; Lucey D; Harrington P; Jordan K; Marshall L; O'Brien KK; Teljeur C
Fam Pract; 2022 May; 39(3):389-397. PubMed ID: 34591966
[TBL] [Abstract][Full Text] [Related]
7. Modelling the Impact and Cost-Effectiveness of Biomarker Tests as Compared with Pathogen-Specific Diagnostics in the Management of Undifferentiated Fever in Remote Tropical Settings.
Lubell Y; Althaus T; Blacksell SD; Paris DH; Mayxay M; Pan-Ngum W; White LJ; Day NP; Newton PN
PLoS One; 2016; 11(3):e0152420. PubMed ID: 27027303
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein point of care testing and physician communication skills training for lower respiratory tract infections in general practice: economic evaluation of a cluster randomized trial.
Cals JW; Ament AJ; Hood K; Butler CC; Hopstaken RM; Wassink GF; Dinant GJ
J Eval Clin Pract; 2011 Dec; 17(6):1059-69. PubMed ID: 20666881
[TBL] [Abstract][Full Text] [Related]
10. Economic considerations support C-reactive protein testing alongside malaria rapid diagnostic tests to guide antimicrobial therapy for patients with febrile illness in settings with low malaria endemicity.
Lubell Y; Chandna A; Smithuis F; White L; Wertheim HFL; Redard-Jacot M; Katz Z; Dondorp A; Day N; White N; Dittrich S
Malar J; 2019 Dec; 18(1):442. PubMed ID: 31878978
[TBL] [Abstract][Full Text] [Related]
11. Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation.
Fraser H; Gallacher D; Achana F; Court R; Taylor-Phillips S; Nduka C; Stinton C; Willans R; Gill P; Mistry H
Health Technol Assess; 2020 Jun; 24(31):1-232. PubMed ID: 32605705
[TBL] [Abstract][Full Text] [Related]
12. The social role of C-reactive protein point-of-care testing to guide antibiotic prescription in Northern Thailand.
Haenssgen MJ; Charoenboon N; Althaus T; Greer RC; Intralawan D; Lubell Y
Soc Sci Med; 2018 Apr; 202():1-12. PubMed ID: 29499522
[TBL] [Abstract][Full Text] [Related]
13. Rapid diagnostic tests versus clinical diagnosis for managing people with fever in malaria endemic settings.
Odaga J; Sinclair D; Lokong JA; Donegan S; Hopkins H; Garner P
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD008998. PubMed ID: 24740584
[TBL] [Abstract][Full Text] [Related]
14. A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): A randomized, controlled non-inferiority trial.
Keitel K; Kagoro F; Samaka J; Masimba J; Said Z; Temba H; Mlaganile T; Sangu W; Rambaud-Althaus C; Gervaix A; Genton B; D'Acremont V
PLoS Med; 2017 Oct; 14(10):e1002411. PubMed ID: 29059253
[TBL] [Abstract][Full Text] [Related]
15. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial.
Bates J; Francis NA; White P; Gillespie D; Thomas-Jones E; Breen R; Kirby N; Hood K; Gal M; Phillips R; Naik G; Cals J; Llor C; Melbye H; Wootton M; Riga E; Cochrane A; Howe R; Fitzsimmons D; Sewell B; Alam MF; Butler CC
Trials; 2017 Sep; 18(1):442. PubMed ID: 28969667
[TBL] [Abstract][Full Text] [Related]
16. A trial-based cost-effectiveness analysis of antibiotic prescription strategies for non-complicated respiratory tract infections in children.
Mas-Dalmau G; Pérez-Lacasta MJ; Alonso-Coello P; Gorrotxategi-Gorrotxategi P; Argüelles-Prendes E; Espinazo-Ramos O; Valls-Duran T; Gonzalo-Alonso ME; Cortés-Viana MP; Menéndez-Bada T; Vázquez-Fernández ME; Pérez-Hernández AI; Muñoz-Ortiz L; Villanueva-López C; Little P; de la Poza-Abad M; Carles-Lavila M;
BMC Pediatr; 2023 Oct; 23(1):497. PubMed ID: 37784098
[TBL] [Abstract][Full Text] [Related]
17. Rapid diagnostic tests to improve treatment of malaria and other febrile illnesses: patient randomised effectiveness trial in primary care clinics in Afghanistan.
Leslie T; Mikhail A; Mayan I; Cundill B; Anwar M; Bakhtash SH; Mohammed N; Rahman H; Zekria R; Whitty CJ; Rowland M
BMJ; 2014 Jun; 348():g3730. PubMed ID: 24948695
[TBL] [Abstract][Full Text] [Related]
18. Rapid Viral Testing and Antibiotic Prescription in Febrile Children With Respiratory Symptoms Visiting Emergency Departments in Europe.
Tan CD; Hagedoorn NN; Dewez JE; Borensztajn DM; von Both U; Carrol ED; Emonts M; van der Flier M; de Groot R; Herberg J; Kohlmaier B; Levin M; Lim E; Maconochie IK; Martinon-Torres F; Nijman RG; Pokorn M; Rivero-Calle I; Strle F; Tsolia M; Vermont CL; Yeung S; Zachariasse JM; Zenz W; Zavadska D; Moll HA;
Pediatr Infect Dis J; 2022 Jan; 41(1):39-44. PubMed ID: 34862345
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of malaria diagnosis using rapid diagnostic tests compared to microscopy or clinical symptoms alone in Afghanistan.
Hansen KS; Grieve E; Mikhail A; Mayan I; Mohammed N; Anwar M; Baktash SH; Drake TL; Whitty CJ; Rowland MW; Leslie TJ
Malar J; 2015 May; 14():217. PubMed ID: 26016871
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and cost-effectiveness of Improving clinicians' diagnostic and communication Skills on Antibiotic prescribing Appropriateness in patients with acute Cough in primary care in CATalonia (the ISAAC-CAT study): study protocol for a cluster randomised controlled trial.
Ruiz R; Moragas A; Trapero-Bertran M; Sisó A; Berenguera A; Oliva G; Borràs-Santos A; García-Sangenís A; Puig-Junoy J; Cots JM; Morros R; Mora T; Lanau-Roig A; Monfà R; Troncoso A; Abellana RM; Gálvez P; Medina-Perucha L; Bjerrum L; Amo I; Barragán N; Llor C
Trials; 2019 Dec; 20(1):740. PubMed ID: 31847912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
